Market Cap

CureVac N.V. Market Capitalization:

€1.03 Billion

EUR as of July 1, 2025

US$1.22 Billion

business CureVac N.V. Company Profile

CureVac N.V. Main Stock Listing

FSX: 5CV

Market Capitalization History of CureVac N.V.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of CureVac N.V. market cap

Date Market Cap YoY Change
Jan. 1, 2025 €902.3 M 0.69%
Jan. 1, 2024 €896.1 M -57.75%
Jan. 1, 2023 €2.12 B -32.79%
Jan. 1, 2022 €3.16 B -76.67%
Jan. 1, 2021 €13.53 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

CureVac N.V. Categories

Germany languages Healthcare languages Biotechnology
Germany Healthcare Germany Biotechnology

Stocks & Indices

CureVac N.V. has the following listings and related stock indices.


Stock: FSX: 5CV

Stock: NASDAQ: CVAC

Stock: XETR: 5CV

Stock: BMV: CVACN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.